# Timerein

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/timerein

- Industry: Biotechnology
- Headquarters: Changzhou, China
- Total disclosed funding: $1.4M
- Latest round: Angel (Sep 15, 2024)
- Investors on record: 2

## About

Founded in 2022 and based in Changzhou, China, Timerein operates as a biotechnology company that focuses on the research and development of medical beauty products. It established ISO13485 quality management system. The company also acquired the Class II medical device registration certificate for the recombinant collagen series products. In September 2024, Timerein raised an angel funding for CNY 10 million.

The company is mainly engaged in the design, development, production, and sales of medical beauty products. It provides solutions that integrate light medical and aesthetic consumables, synthetic biological regenerative materials, and optoelectronic active equipment. Its main products are recombinant collagen sterile dressings, recombinant collagen freeze-dried fibers, etc.

The company generates revenue by selling recombinant collagen products.

The company will use the angel funding to build the production line of the biological incubation platform, produce recombinant type XVII collagen, and develop medical beauty materials. The company will continue to invest in the research and development of more recombinant collagen products in the future.

## Funding rounds

- Angel, Sep 15, 2024, $1.4M — China Venture Capital, Juhai Venture Capital

## Investors

- China Venture Capital (https://capitalatlas.ai/funds/china-venture-capital) — Angel
- Juhai Venture Capital — Angel